Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE
Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE. // Respiratory Medicine and Research. – URL: https://www.sciencedirect.com/science/article/pii/S2590041226000711?dgcid=rss_sd_all
Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE. Respiratory Medicine and Research. https://www.sciencedirect.com/science/article/pii/S2590041226000711?dgcid=rss_sd_all
“Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.” Respiratory Medicine and Research.
@article{article64357,
title = {Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE},
journal = {Respiratory Medicine and Research},
url = {https://www.sciencedirect.com/science/article/pii/S2590041226000711?dgcid=rss_sd_all}
}